Related Experiment Video
Updated: Jun 21, 2026

Cryopreservation and Bioenergetic Evaluation of Human Peripheral Blood Mononuclear Cells
Published on: October 20, 2023
Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic
J Wong1, S V McLennan, L Molyneaux
1Diabetes Centre, Royal Prince Alfred Hospital, Level 6, West Wing, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia. jencia.wong@email.cs.nsw.gov.au
Aims/Hypothesis:
We examined whether age of type 2 diabetes onset is related to mitochondrial DNA content in peripheral blood monocytes (PBMCs).
Methods:
PBMCs were isolated from 65 patients with type 2 diabetes. To minimise age as a confounder, only patients aged >or=50 years were studied. Sample mitochondrial DNA (mtDNA) content was determined by amplification of the mitochondrial gene CYT-B (also known as MT-CYB) and adjusted for single-copy nuclear control genes (36B4 [also known as RPLPO] and GAPDH).
Results:
Age of diabetes onset ranged from 25 to 69 years. There was a significant positive relationship between age of diabetes onset in quartiles and mtDNA content for the whole group (p = 0.02 for trend). When stratified by the presence of diabetes complications, a strong positive relationship was observed between age of diagnosis and mtDNA content for participants without diabetic complications (r = 0.7; p = 0.0002), but not for those with complications (r = -0.04; p = 0.8). Multivariate analysis confirmed age of onset and complication status as independent determinants. There was co-linearity between age of onset and disease duration, with similar relationships also seen between duration and mtDNA content.
Conclusions/Interpretation:
An earlier age of type 2 diabetes onset is associated with a lower PBMC mtDNA content, but only in patients without diabetes complications. This may reflect a differing biology of PBMC mtDNA in those with early-onset diabetes and those who are prone to complications. PBMC mtDNA depletion may accelerate diabetes onset; however the independent effect of diabetes duration remains to be evaluated.
Insights
Earlier type 2 diabetes onset correlates with lower mitochondrial DNA (mtDNA) in peripheral blood monocytes (PBMCs), but only in patients without complications. This suggests differing biology in early-onset diabetes without complications.
Area of Science:
- Endocrinology
- Mitochondrial Biology
- Genetics
Background:
- Mitochondrial dysfunction is implicated in type 2 diabetes.
- Mitochondrial DNA (mtDNA) content in peripheral blood monocytes (PBMCs) may serve as a biomarker.
Purpose of the Study:
- To investigate the relationship between the age of type 2 diabetes onset and mtDNA content in PBMCs.
- To explore if this relationship is modified by the presence of diabetes complications.
Main Methods:
- PBMCs were isolated from 65 type 2 diabetes patients aged >=50 years.
- mtDNA content was quantified using gene amplification and normalized to nuclear genes.
- Participants were stratified based on the presence or absence of diabetes complications.
Main Results:
- A significant positive trend was observed between age of diabetes onset and PBMC mtDNA content in the overall cohort.
- A strong positive association was found between age of onset and mtDNA content in patients without complications (r=0.7, p=0.0002).
- No significant association was observed in patients with diabetes complications (r=-0.04, p=0.8).
Conclusions:
- Earlier type 2 diabetes onset is associated with lower PBMC mtDNA content, specifically in patients without diabetes complications.
- This finding suggests distinct pathophysiological mechanisms in early-onset diabetes without complications.
- PBMC mtDNA depletion might contribute to earlier diabetes onset, though diabetes duration's independent effect requires further study.
Related Concept Videos
Mitochondria
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes: Symptoms, Diagnosis, and Complications
Type I Diabetes II: Pathophysiology
Diabetic Retinopathy
